Kilitch Drugs (India) (BOM:524500) YoY EBITDA Growth : 11.30% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kilitch Drugs (India)'s YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 11.30%.

Kilitch Drugs (India)'s EBITDA per Share for the three months ended in Dec. 2023 was ₹3.33.

Kilitch Drugs (India) YoY EBITDA Growth Historical Data

The historical data trend for Kilitch Drugs (India)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) YoY EBITDA Growth Chart

Kilitch Drugs (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

29.63

-62.66

81.16

67.98

54.11

Kilitch Drugs (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															125.81	32.90	53.03	108.95	11.30

Kilitch Drugs (India) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kilitch Drugs (India)'s YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(13.146	-	8.53)	/	\| 8.53 \|
=	54.11 %

Kilitch Drugs (India)'s YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(3.33	-	2.992)	/	\| 2.992 \|
=	11.30 %

Kilitch Drugs (India) YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kilitch Drugs (India) (BOM:524500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

KILITCH:India

Address

Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088

Website

https://www.kilitch.com

Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business. The company has a geographical presence in African countries and several Asian countries.

Kilitch Drugs (India) (BOM:524500) Headlines

No Headlines